Current diabetes and metabolic health news selected for patient safety, public usefulness, novelty, and evidence strength.News posts summarize source material in plain language and include practical takeaways. They are not individualized medical advice and should not replace clinician guidance.
Retatrutide: A New Horizon in Diabetes and Obesity Management: evidence-based guidance reviewed against current NICE and ADA recommendations. Practical.
New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar: cardiovascular outcome trial evidence, who benefits most, and how this drug.
